Foresight Collaborates with One of the World’s Largest Electric Vehicle Brands
December 29, 2023 07:15 ET
|
Foresight Autonomous Holdings Ltd.
Parties sign collaboration agreement to evaluate Foresight's 3D perceptioncapabilities for enhancing the manufacturer’s automotive vision solutions Ness Ziona, Israel, Dec. 29, 2023 (GLOBE...
PharmaTher and Vitruvias Enter Into Collaboration Agreement for Commercialization of KETARX™ (racemic ketamine) in the U.S.
June 20, 2023 07:00 ET
|
PharmaTher Holdings Ltd.
TORONTO, June 20, 2023 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a commercial-focused specialty pharmaceutical company, is pleased to...
Collaboration and Licensing Agreement
August 18, 2022 02:00 ET
|
DXS International PLC
DXS INTERNATIONAL PLC COLLABORATION AND LICENSING AGREEMENT The Board of DXS International plc (“the Company”), the AQSE Growth Market quoted healthcare information and digital clinical decision...
STTK SHAREHOLDER ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Shattuck Labs, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – STTK
March 07, 2022 14:01 ET
|
The Rosen Law Firm PA
NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Shattuck Labs, Inc. (NASDAQ: STTK): (i) pursuant and/or...
STTK INVESTOR NEWS: ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Shattuck Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – STTK
February 01, 2022 09:45 ET
|
The Rosen Law Firm PA
NEW YORK, Feb. 01, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of...
Citrine Global Corp.’s (OTCQB: CTGL) Subsidiary, Cannovation Center Israel Ltd., is Pleased to Announce the Launch of its "Green Side by Side" Products Line and the Signing of an Agreement with Intelicanna to Sell the Products in Israel
January 21, 2022 09:35 ET
|
Citrine Global, Corp.
Tel Aviv, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Citrine Global Corp.’s (OTCQB: CTGL) subsidiary, Cannovation Center Israel Ltd. (Cannovation), announced that it has launched its "Green Side by Side"...
Arbutus Biopharma and Vaccitech Announce Clinical Trial Collaboration Agreement to Evaluate RNAi Therapeutic, AB-729, in Combination with Immunotherapeutic, VTP-300, in Subjects with Chronic Hepatitis B Virus Infection
July 06, 2021 07:00 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa. and OXFORD, United Kingdom, July 06, 2021 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) and Vaccitech plc (Nasdaq: VACC) today announced that the companies have...
Arbutus Biopharma and Antios Therapeutics Announce Clinical Collaboration Agreement to Evaluate AB-729 in Combination with ATI-2173 in Subjects with Chronic Hepatitis B Virus Infection
June 29, 2021 07:00 ET
|
Arbutus Biopharma Corporation
MENDHAM, N.J. and WARMINSTER, Pa., June 29, 2021 (GLOBE NEWSWIRE) -- Antios Therapeutics, Inc. and Arbutus Biopharma Corporation (Nasdaq: ABUS) today announced that the companies have entered into a...
GTX Corp Signs Collaboration Agreement with Pawtocol
January 21, 2021 09:54 ET
|
GTX Corp
LOS ANGELES, CALIFORNIA, Jan. 21, 2021 (GLOBE NEWSWIRE) -- GTX Corp (OTC: GTXO) (“GTX” or the “Company”), a pioneer in the field of health and safety wearable GPS human and asset tracking systems,...
uniQure and Gen-X Enter into Research Collaboration and License Agreement for the Development of Novel Synthetic Promoters
March 02, 2020 16:05 ET
|
uniQure Inc.
~ Gen-X Will Work with uniQure During an Exclusivity Period to Identify Novel Promoters for uniQure’s Product Portfolio ~ ~ uniQure Receives Option to Acquire Gen-X Business for Use in Gene Therapy ~...